Propylthiouracil
- Product NDC
- 62135-606
- 11-digit product format
- 621350606
- Labeler code
- 62135
- Product ID
- 62135-606_0d6cc91d-1da2-25ae-e063-6394a90aa6a0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Propylthiouracil
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA080016
- Marketing category
- ANDA
- Marketing start
- 1982-01-01
- Substance
- PROPYLTHIOURACIL
- Active strength
- 50 mg/1
- Pharmacologic classes
- Thyroid Hormone Synthesis Inhibitor [EPC], Thyroid Hormone Synthesis Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Propylthiouracil
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PROPYLTHIOURACIL | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 721M9407IY |
| Rxcui | 198175 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-606-90 | Propylthiouracil | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-606 | PROPYLTHIOURACIL TABLET [CHARTWELL RX, LLC] | 1 | Current NDC, 1 package rows | 20231227_53c5f586-3e72-479d-89ba-379683c8f6ba.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-606-90 | 62135060690 | 90 TABLET in 1 BOTTLE (62135-606-90) | 90 tablet | 2023-12-19 | No | No | Historical |